# Hematopoietic Agents

## Length of Authorizations

Dependent upon diagnosis

## Additional Criteria

### Approval of epoetin alfa or darbepoetin

| Diagnosis                                                    | Hemoglobin Level | Approval Length |
| ------------------------------------------------------------ | ---------------- | --------------- |
| Anemia due to chronic renal failure, patient on dialysis     | \<=11            | 365 days        |
| Anemia due to chronic renal failure, patient not on dialysis | \<=10            | 365 days        |
| Chemotherapy-induced anemia                                  | \<=10            | 90 days         |
| Anemia in myelodysplastic syndrome                           | \<=11            | 180 days        |

### Approval of epoetin alfa only (not darbepoetin)

| Diagnosis                                                                           | Hemoglobin Level | Approval Length |
| ----------------------------------------------------------------------------------- | ---------------- | --------------- |
| Autologous blood donation, patient will require blood transfusions                  | \>10, \<=13      | 30 days         |
| Anemia of prematurity, age \<=6 months                                              | N/A              | 42 days         |
| Anemia associated with chronic inflammatory disorders (e.g., rheumatoid arthritis)  | \<=11            | 180 days        |
| Anemia associated with ribavirin combination therapy in hepatitis Cinfected patient | \<=11            | 180 days        |
| Anemia in zidovudine-treated HIV-infected patients                                  | \<=11            | 180 days        |

### Prior Authorization

1.  Is there any reason the patient cannot be changed to a medication not requiring prior approval? Acceptable reasons include:
-   Allergy to medications not requiring prior approval
-   Contraindication to all medications not requiring prior approval
-   History of unacceptable/toxic side effects to medications not requiring prior approval
1.  Has the patient failed a therapeutic trial of **14 days** with one preferred medication?

## Formulary

Blood Agents: Blood Formation, Coagulation, and Thrombosis Agents: Hematopoietic Agents

### Preferred

| Preferred   |      |
| :---------- | ---: |
| Epogen PA   |      |
| Mircera PA  |      |
| Retacrit PA |      |

### Non-Preferred

| Non-Preferred |      |
| :------------ | ---: |
| Aranesp       |      |
| Procrit       |      |

## Links

[Criteria](https://pharmacy.medicaid.ohio.gov/sites/default/files/20221001_UPDL_Criteria_APPROVED.pdf#page=11)

[Preferred Drug List](https://pharmacy.medicaid.ohio.gov/sites/default/files/20221001_UPDL_APPROVED_.pdf#page=8)